13D Filing: OrbiMed Advisors and Roka Bioscience Inc. (ROKA)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of § 240.13d-1(e), 240.13d...